Proteome Sciences Extends its Reach Through Collaboration with MedBiomix Partners
News Feb 04, 2015
MedBiomix Partners SAS and Proteome Sciences Ltd have announced that they enter into a collaborative network alliance, whose goal is to provide healthcare professionals with advanced data-driven solutions to integrate and make better use of protein expression data that will significantly improve the life and disease conditions of their patients.
“The understanding of human disease and execution of personalized medicine requires the use of multi-scale analysis”, says Patrice Denèfle, Co-founder of MedBiomiX Partners, “we are delighted to engage with Proteome Sciences as a new partner in our growing network of excellence as their knowledge in measurement of protein expression and post-translational modifications will bring an additional, very important dimension to our set of expertise beyond DNA and RNA analysis”.
Ian Pike, Chief Operating Officer of Proteome Sciences added: “We are excited to join the MedBiomix network which will further extend the reach of our powerful proprietary tools and technologies to support and enhance the development and delivery of personalized medicine approaches to improve treatment programmes for patients with cancer and neurological conditions.”
Protein's Role in Mitochondrial Metabolism IdentifiedNews
EXD2, a protein previously thought to be localised to the nucleus, has a key role in the production of proteins by mitochondria.READ MORE
Proteasome Blocker Brings Glaucoma Gene Therapy CloserNews
An enhanced gene therapy technique that pairs a viral vector with a proteasome blockade has doubled the therapy's efficiency.READ MORE